Banning Misleading Drug Ads Act of 2022
Summary
Banning Misleading Drug Ads Act of 2022 This bill finalizes a 2010 proposed rule from the Food and Drug Administration (FDA) regarding television and radio prescription drug advertisements if the FDA does not otherwise issue a final rule within 180 days of the bill's enactment. (The proposed rule specifies standards for major statements about a drug's side effects in television and radio advertisements.)
Bill status
in committee
1 of 4 stages cleared
Introduction
Jul 2022
Committee Review
Floor Vote
President
Introduced Jul 5, 2022
Last action Jul 5, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Jul 5, 2022
House · Referred to committee
Referred to the House Committee on Energy and Commerce.
Jul 5, 2022
House · Introduced
Introduced in House
1 primary · 5 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 8289
Scope: US
Hi! I can help you understand HR 8289. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline